Kinstellar and Orrick advised Dream Games on the deal while Goodwin Procter represented Index Ventures. Dream Games raised USD 255 million in a Series C investment round...
Dream Games’ $255 Million Series C Investment Round
Novo’s $90 Million Series B Preferred Stock Financing
Goodwin Procter advised Novo on the deal. Novo announced the completion of its $90 million Series B Preferred Stock financing that values the startup at $700 million....
Acadia Pharmaceuticals’ Collaboration Agreement with Stoke Therapeutics
Goodwin Procter advised Acadia Pharmaceutical on the deal while Wilson Sonsini represented Stoke Therapeutics. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced its collaboration agreement with Stoke Therapeutics, Inc....
Arrakis Therapeutics’ Collaboration Agreement with Amgen
Goodwin Procter advised Arrakis Therapeutics on the deal. Arrakis Therapeutics announced its research collaboration agreement with Amgen (NASDAQ:AMGN), focused on the discovery and development of RNA degrader...
FountainVest Partners’ Acquisition of China F&B Group
Goodwin Procter advised FountainVest Partners on the deal. FountainVest Partners announced its acquisition of China F&B Group from EQT Partners. China F&B Group operates two renowned international...
Metaversal Ventures’ $50 Million Series A Financing Round
Goodwin Procter advised Metaversal Ventures on the deal. Metaversal Ventures, Inc. announced its $50 million Series A financing round. The round was co-led by CoinFund and Foxhaven...
York Private Equity and Cennox’s Acquisition of Mick’s Vault Works
Goodwin Procter advised York Private Equity and Lennox on the deal. York Capital Management’s private equity group (York Private Equity) and Cennox announced their acquisition of Mick’s...
Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix
Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...
Permira’s Investment in BPL and Kedrion
Goodwin Procter advised Bio Products Laboratory and Tiancheng International Investment Limited on the deal. The shareholders of Kedrion was advised by Carnelutti and Pedersoli Studio Legale,...
Dennis et al v. JPMorgan Chase & Co. et al.
Lovell Stewart Halebian Jacobson LLP and Lowey Dannenberg assisted the plaintiffs. Sullivan & Cromwell LLP assisted Australia and New Zealand Banking Group Ltd., National Australia Bank...
Ankorstore’s €250 Million Funding Round
Goodwin Procter advised BOND on the deal. August Debouzy advised Tiger Global Management and Coatue while Gunderson Dettmer represented Tiger Global Management. Bredin Prat advised Eurazeo...
Amylyx Pharmaceuticals’ $190 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...